Tritrp-Orn
General Information
DRACP ID DRACP00957
Peptide Name Tritrp-Orn
Sequence VOOFPWWWPFLOO
Sequence Length 13
UniProt ID Not available
PubChem CID Not available
Origin porcine cathelicidin peptide
Type Synthetic peptide
Classification
Active ACP
Activity Information
Cell Line | Disease | Cancer Classified | Activity | Assay | Testing Time | Literature |
---|---|---|---|---|---|---|
Jurkat | Childhood T acute lymphoblastic leukemia; Precursor T-cell acute lymphoblastic leukemia | Leukemia | IC50 ≤ 6.5 µM | MTT assay | 24h | 1 |
Hemolytic Activity RBC: IC50 ≥ 65 µM
Normal (non-cancerous) Cytotoxicity PBMC: IC50=38.1 µM
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Amidation
Other Modification O=Ornithine
Chiral L
Physicochemical Information
Formula C72H76N12O6
Absent amino acids ACDEGHIKMNQRSTY
Common amino acids W
Mass 141968
Pl 6.11
Basic residues 0
Acidic residues 0
Hydrophobic residues 7
Net charge 0
Boman Index 2191
Hydrophobicity 59.23
Aliphatic Index 52.31
Half Life
/
Extinction Coefficient cystines 16500
Absorbance 280nm 1375
Polar residues 0
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 32126228
Title Selective anticancer activity of synthetic peptides derived from the host defence peptide tritrpticin
Doi 10.1016/j.bbamem.2020.183228
Year 2020
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available